Novartis AG is 154.0x more valuable than Lakefront Biotherapeutics NV by market capitalization ($293.70 B vs $1.91 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | LKFT | NVS |
|---|---|---|
| Market cap | $1.91 B | $293.70 B |
| US-listed rank | #2140 | #46 |
| SEC filings | 511 | 947 |
Novartis AG is 154.0x more valuable than Lakefront Biotherapeutics NV by market capitalization ($293.70 B vs $1.91 B).
Full pages: Lakefront Biotherapeutics NV and Novartis AG, or browse the full rankings.